Osteopontin contains an arginine-glycine-aspartic acid (RGD) sequence, which is essential for its interaction with integrins. This interaction facilitates cell adhesion and migration, making osteopontin a key player in wound healing and tissue repair . Additionally, osteopontin is involved in bone mineralization by binding to hydroxyapatite, a major component of bone .
Recombinant human osteopontin is produced using various expression systems, including HEK293 cells and mouse myeloma cell lines. The recombinant protein is typically purified to high levels of purity, often exceeding 95%, and is used in various research applications . The recombinant form of osteopontin retains its functional properties, including its ability to enhance cell adhesion and support cell migration .
Recombinant osteopontin is widely used in research to study its role in various biological processes. It is utilized in cell adhesion assays, migration studies, and investigations into its involvement in chronic inflammatory diseases and cancer . The protein’s ability to interact with integrins and CD44 makes it a valuable tool for understanding cell signaling pathways and developing therapeutic strategies.
Osteopontin has been implicated in several diseases, including cancer, cardiovascular diseases, and autoimmune disorders. Its overexpression is often associated with tumor progression and metastasis, making it a potential biomarker for cancer diagnosis and prognosis . Additionally, osteopontin’s role in inflammation and immune responses highlights its potential as a therapeutic target for inflammatory diseases .